How much has NeuShen Therapeutics raised?

NeuShen Therapeutics has raised $100M across 2 sourced rounds on record. The latest is $80M (Series B+), announced September 7, 2026.

Who invested in NeuShen Therapeutics?

Investors on record for NeuShen Therapeutics: B Capital, BioVenture, Lapam Capital, Legend Capital, Lilly Asia Ventures, Matrix Partners China, Pivotal bioVenture Partners, Qiji Investment and 2 others. Lapam Capital led a round.

Where is NeuShen Therapeutics based?

NeuShen Therapeutics is based in Shanghai, China.

NeuShen Therapeutics

We are a global biotech company committed to developing new and effective therapies for psychiatric and neurological disorders affecting millions of patients in need.

Health and bio

NeuShen Therapeutics is a company based in Shanghai, China. Recent Funding lists it under Health and bio. It raised $80M in a Series B+ round in September 2026, according to thepharmaletter.com. Recent Funding has 2 sourced rounds on record for it, totaling $100M, the first in September 2022. Investors on record include B Capital, BioVenture, Lapam Capital, Legend Capital and 6 others.

Website: neushen.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Medical, Mental Health, Neuroscience, Psychology.

Stage: Series B+.

Based in: Shanghai, China.

Total raised: $100M in 2 sourced rounds.

Last round: Sep 7, 2026 · 35 days ago.

Domain age: 5 years.

On Recent Funding since: Oct 9, 2026.

TIMELINE · MONEY RAISED

NeuShen Therapeutics | 479 days from website to first raise on record

Raised $100M in 2 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

September 7, 2026
Series B+ · $80M
BB Capital, LLegend Capital, LLilly Asia Ventures, MMatrix Partners China, SShanghai Guotou Pioneer, TTruMed Investment
Source: thepharmaletter.com
September 29, 2022
Seed · $20M
LLapam Capital (lead), BBioVenture
Source: prnewswire.com
June 7, 2021
Website created

Investors

NeuShen Therapeutics: questions and answers

How much has NeuShen Therapeutics raised?: NeuShen Therapeutics has raised $100M across 2 sourced rounds on record. The latest is $80M (Series B+), announced September 7, 2026.
Who invested in NeuShen Therapeutics?: Investors on record for NeuShen Therapeutics: B Capital, BioVenture, Lapam Capital, Legend Capital, Lilly Asia Ventures, Matrix Partners China, Pivotal bioVenture Partners, Qiji Investment and 2 others. Lapam Capital led a round.
Where is NeuShen Therapeutics based?: NeuShen Therapeutics is based in Shanghai, China.

Similar Health and bio companies

AAlo Hakeem$165K Pre Seed · Oct 2026
NNat Habit$14.68M Series B+ · Oct 2026
GGramiyaa$1.93M Series A · Oct 2026
PPhantom GI$5M Seed · Oct 2026
YYazen$55.93M · Oct 2026
MMMI$125M Series B+ · Oct 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/neushen-therapeutics (get a free API key).